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ABSTRACT
A new reversed phase high pressure liquid chromatography and a spectrophotometric method are proposed for the simultaneous determination of diflucortolone valerate (DIF) and chlorquinaldol (CHL) in creams. An isocratic system consisted of an ACE®
C18 analytical column and a mobile phase composed of methanol/phosphate buffer (pH 5.5, 0.1 M) (95:5, v/v) at a flow rate 1.0
mL/min was used for the optimal chromatographic separation using UV detection at 220 nm. Ephedrine hydrochloride was used
as internal standard. Principal component regression (PCR) was used as the chemometric technique in spectrophotometry. In this
technique, the concentration data matrix was prepared by using the synthetic mixtures containing these drugs in methanol/water
(3:1). The absorbance data matrix corresponding to the concentration data matrix was obtained by measuring the absorbances at
60 wavelengths in the range of 230-348 nm with appropriate interval Δλ of 2 nm for DIF and CHL in the zero-order spectra for the
binary combinations. The linear ranges were found 2.40-300 µg/mL for DIF, 0.72-240 µg/mL for CHL for LC method, and 0.88-3.0
µg/mL for DIF and 1.0-11.2 µg/mL for CHL for PCR method. The accuracy, precision and the linear ranges of the methods have
been evaluated and they have been validated by analyzing synthetic mixtures containing the title drugs. These two methods were
successfully applied to two pharmaceutical cream preparations and the results were compared with each other.
Key words: diflucortolone valerate, chlorquinaldol, principal component regression, pharmaceutical preparation, liquid chromatography

INTRODUCTION
C h lor q u i n a ldol (C H L) (5 -7-D ich lor o -2-me t hylquinolin-8-ol) is used as antimicotic and antifungal
in the treatment of infection of skin and vagina that is
administrated topically. Dif lucortolone valerate (DIF)
(6α9αDif loro-11β21-dihydroxy-16αmethylpregna-1,4diene-3,20-dione 21 valerate) is a corticosteroid that is
used in the inflammation of skin. Binary combinations
of these drugs are frequently prescribed as antimicrobial
drugs. The structures of these drugs are shown in Figure 1.
There are few examples of published methods for
the determination of CHL and DIF alone or in their
mixture with other substances. A gas-liquid chromatographic method was used for the determination of CHL
and chlortalidone in biological materials (1). A polarographic technique was applied for the determination of
CHL alone in a pharmaceutical preparation (2). A spectrofluorimetric method was used to determination CHL
in the presence of chloroxine in pharmaceutical preparations (3). High pressure liquid chromatography (HPLC)
methods are described for the analysis of DIF alone in
pharmaceutical dosage forms (4-7). However, no information concerning the simultaneous determination of CHL
and DIF in their binary mixture or in pharmaceutical
preparations could be seen in the literatures.
* Author for correspondence. Tel: +90-312-212-68-05;
Fax: +90-312-2130-10-81; E-mail: onur@pharmacy.ankara.edu.tr

Chromatographic techniques are most widely used
for resolving mixtures. However chemometric techniques (multivariate calibration techniques), based on
the computer aided instrumentation and algoritms, are
employed for the analysis of multicomponent samples.
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Figure 1. The structures of chlorquinaldol and dif lucortolone
valerate

146
Journal of Food and Drug Analysis, Vol. 15, No. 2, 2007

A certain number of calibration methods are available
as an affordable commercial software is used with existing instruments. The most popular among them include
CLS (classical least squares), ILS (inverse least squares),
PCR (principle component regression) and PLS (partial
least squares). The joining spectrophotometric data and
multivariate calibration techniques for the resolution of
mixtures of analytes with overlapped spectra becomes
a useful tool for developing new analytical methods.
All of the chemometric spectral analysis techniques are
useful for the resolution of spectral bands overlapping
in quantitative determination. Main advantage of these
techniques is the simultaneous analysis of the mixture
components without chemical pre-treatment or graphical
procedure of spectra such as derivative and ratio spectra
derivative. They also require shorter time, less costs and
simple instrumentation.
The aim of this study was to develop a LC method
and a chemometric technique in spectrophotometry that
allow the simultaneous determination of DIF and CHL in
their mixture and in cream formulations.

MATERIALS AND METHODS
I. Apparatus
Shimadzu 1601 PC double beam spectrophotometer
with a fixed slit width (2 nm) connected to a computer
loaded with Shimadzu UVPC was used for the spectrophotometric measurements.
In spectrophotometric methods, zero-order spectra
of the solution of DIF and CHL in methanol in the range
of 200-300 nm were used.
An Agilent Technologies HP 1100 chromatographic
system equipped with a model series of G13 79A degasser,
G1311A quaternary pump, 61313A injector and G1315B
DAD detector was used. ACE ® C18 column 250 × 4.6
mm, particle size 5 µm was used. The chromatograms
were recorded and the peaks were quantitated using the
automatic integrator. The mobile phase was methanol phosphate buffer (pH 5.5, 0.1 M) (95:5, v/v). The flow rate
was set at 1 mL/min with 20 mL as injection volume and
the detection wavelength was 220 nm. Ephedrine hydrochloride was used as internal standard (IS).
II. Computer Software and Hardware
In chemometric procedure, Multivariate Analysis
Add-in for Excel v1.3 [8] software was used and run on a
Pentium III, 128 MB RAM, 1500 MHz computer.
III. Materials
Chlorquinaldol and dif lucortolone valerate were
obtained from Intendis, Turkey and they were used
without further purification. Methanol Chromasolv ® of

HPLC gradient grade was provided by Sigma Aldrich.
Water for preparation of solution was produced in-house
by the PurelabUHQ water purification system (Elba).
The mobile phase and the solution for injection were
degassed in an ultrasonic bath and were filtered through
the 0.45 µm nylon membrane before use.
IV. Standard Solutions
Solutions of DI F (10 mg /50 m L) and CH L (10
mg/50 mL) were prepared in methanol/water (3:1) for
PCR method and solutions of DIF (50 mg/100 mL) and
CHL (50 mg/100 mL) were prepared in methanol for LC
method. Solution of 100 mg/100 mL ephedrine hydrochloride was prepared in same solvent as IS as stock
solution for LC method.
V. Sample Preparation
(1) For LC: 1 g of Nerisona® C or Impetex® cream
was weighed in 50-mL volumetric f lask and diluted to
volume with methanol. After 30 min of mechanically
shaking and 15 min of standing in the dark, the solution was filtered through a 0.45-µm Millipore filter into
another 50-mL volumetric flask. Then the volume was
completed to the mark with methanol (I). I (12.5 mL)
and IS stock solution (2.5 mL) were put into a 25-mL
volumetric flask and the volume was completed to 25 mL
with methanol (II). Solution II can be injected into the
chromatographic system.
(2) For PCR: 1 g of Nerisona® C or Impetex® cream
was weighed in 50-mL volumetric f lask and diluted
to volume with methanol/water (3:1). After 30 min of
mechanically shaking and 15 min of standing in the
dark, the solution was filtered through a 0.45-µm Millipore filter into another 50-mL volumetric flask. Then the
volume was completed to the mark with methanol/water
(3:1) (I). Then 1.25 mL of I was added into a 25-mL
volumetric flask and the volume was completed to 25 mL
with methanol/water (3:1) (II). The absorbances of the
solution II were measured at the selected wavelengths.
VI. Commercial Pharmaceutical Preparations
NERISONA C cream (1 mg diflucortolone valerate
and 10 mg chlorquinaldol/1 g cream) from Intendis, Turkey
(batch no: 59098) and IMPETEX cream (1 mg diflucortolone valerate and 10 mg chlorquinaldol/1 g cream) from
Roche, Turkey (batch no: IT0004) were assayed.

RESULTS AND DISCUSSION
I. LC Method
First, the pH and concentration of mobile phase
were optimized for the separation on ACE® C18 column.
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0.1 M Phosphate buffer (pH 5.5, 0.1 M) was selected
for suitable separation. Beside this, the solvent content
in mobile phase was studied on the same column. The
optimal mobil phase for good separations was found to
be methanol/phosphate buffer (pH 5.5, 0.1 M) (95:5, v/v).
Furthermore, the flow rate, column temperature and injection volumes were also optimized to be 1 mL/min, 25°C
and 20 µL, respectively. As for the IS, pseudoephedrine
hydrochloride, timolol maleat, dorzolamid, ephedrine
hydrochloride and phenylephrine hydrochloride were
tested. Ephedrine hydrochloride could be successfully
separated from other compounds so that it was used as
IS in this study. Also, the detection wavelength, 220 nm,
was chosen according to absorption spectra of all three
substances.
Thereupon, ACE® C18 column (250 × 4.6 mm, 5 µm),
mobile phase composed of methanol/phosphate buffer (pH
5.5, 0.1 M) (95:5, v/v) at 1 mL/min flow rate, 25°C column
temperature and 20 µL injection volume were finally
employed for the optimal separations. System suitability
test were done and the results were shown in Table 1. For
separation factor, the IS was taken as the reference peak.
Under these chromatographic conditions, ephedrine
hydrochloride, DIF and CHL peaks were well resolved
and their retention times were found 2.53, 3.44 and 4.46
min, respectively. A typical chromatogram of the drugs
and internal standard was illustrated in Figure 2.
Each solution was injected three times and the areas
of peaks, as measured at 220 nm, were integrated. The
ratios of the peaks areas of investigated substances to that
of IS were calculated for each injection. Regression equaTable 1. System suitability tests results for DIF and CHL in LC
method
DIF

CHL

5.86

7.85

Separation factor

1.45

1.33

Resolution

4.51

4.97

Asymmetry

0.906

0.899

DAD1 D. Sig=220.18 Ref = off (DILEK\DK000206.D)

mAU

II. PCR Method
(I) Method
The original data obtained in absorbances (A) and
concentrations (C) of analytes were reprocessed by standardizing as A0 and C 0, respectively. Using the ordinary
linear regression with coefficients a and b:
C=a+b×A
b = P × q, where P is the matrix of eigenvectors and
q is the C – loadings given by q = D × T T × A0. Here
T T is the transpose of the score matrix T. D is a diagonal matrix with the inverse of the selected eigenvalues
as components. Knowing b one can easily find a by the
formula a = Cmean – ATmean × b, where ATmean represents
the transpose of the matrix with the entries of the mean
absorbance values and C mean is the mean concentration
of the calibration set. Multivariate Analysis Add-in for
Excel v1.3 software [8] was used for the calculation.
(II) Procedure
The zero-order absorption spectra for DIF and CHL
and their binary mixture in methanol/water (3:1) were

2.538

Parameter
Retention factor

tion was established by plotting the ratio of peak areas to
the concentration of each substance. Linearity was found
in the range of 2.40-300 µg/mL for DIF and 0.72-240
µg/mL for CHL. The calculation method of LOQ (limit
of quantitation) is based on the standard deviation (SD)
of the response and the slope (m) of the calibration curve
according to the formula: LOQ = 10 (SD/m). LOD (limit
of detection) can be calculated based on the SD of the
response and the slope (m) of the calibration curve according to the formula: LOD = 3.3 (SD/m). LOQ values were
calculated as 2.40 µg/mL for DIF and 0.037 µg/mL for
CHL. LOD values were calculated as 0.79 and 0.24 µg/mL
for DIF and CHL respectively (Table 2). Mean recoveries,
relative standard deviations and confidence interval for this
method found in synthetic mixtures were shown in Table 2.
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Figure 2. Typical chromatogram of a) ephedrine HCl (internal standard) (250 mg/mL), b) diflucorotolone valerate (80 mg/mL) and, c)
chlorquinaldol (80 mg/mL) in HPLC method for pharmaceutical preparations.
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Table 2. Linearity parameters and recovery results of DIF and CHL
in LC method
CHL

2.40-300

0.72-240

Slope of the calibration
curve ± standard error

0.1504 ± 0.0002

0.8210 ± 0.0026

Intercept of the calibration
curve ± standard error

0.2224 ± 0.0087

0.014 ± 0.0030

0.9998

0.9999

0.79

0.24

r
LOD (µg/mL)
LOQ (µg/mL)

2.40

0.72

Mean recovery %

100.5

100.6

*RSD %

1.58

0.99

Confidence interval for p =
0.05

1.18

0.80

*RSD: relative standard deviation.

Table 3. Training set used in PCR method for DIF and CHL.
Mixture

CHL (µg/mL)

DIF (µg/mL)

1

1

0,88

2

1

2,6

3

1

3

4

4

0,88

5

4

1,2

6

4

2,6

7

4

3

8

6

0,88

9

6

1,2

10

6

2,6

11

6

3

12

11,2

0,88

13

11,2

2,6

14

11,2

3

shown in Figure 3. The spectra of both components were
overlapped in the range of 200-350 nm. So, it is impossible to determine DIF or CHL in their mixture (Figure
3C) by measuring the absorbances at their λ max or any
other wavelengths without interference of each other.
PCR technique was employed for the simultaneous determination of DIF and CHL in their binary combination
using the zero-order absorption spectra of their mixture
without any prior separation technique. Other chemometric techniques such as CLS, ILS and PLS methods
have been proven unsuccessful in the simultaneous analysis of DIF and CHL in their mixture.
In PCR technique, for the determination of DIF and
CHL in their binary mixture, optimal conditions were
investigated and absorbance data matrix were obtained
by measuring the absorbance between 230-348 nm with a

0.200

a
Abs.

DIF
Linearity range (µg/mL)

0.260

c
b
0.100

0.000
200.0

250.0

300.0

350.0

400.0

Wavelength (nm)

Figure 3. Zero-order absorption spectra of a) 3.2 mg/mL solution of
DIF, b) 0.96 mg/mL solution of CHL, c) solution containing 3.2 mg/
mL DIF and 0.96 mg/mL CHL mixture in methanol/distilled water
(3:1).

Table 4. Linearity parameters, recovery and statistical results of
DIF and CHL in PCR technique
Parameter

DIF

CHL

0.88-3.00

1.0-11.2

0.9986

0.9999

LOD (µg/mL)

0.32

0.30

LOQ (µg/mL)

0.86

1.00

Mean recovery %

99.9

100.1

Linearity range (µg/mL)
Regression coefficient

RSD %

2.7

0.6

Confidence interval for p = 0.05

1.80

0.40

interval Δλ of 2 nm at 60 wavelengths for DIF, CHL and
their binary mixtures. The calibration was obtained by
using the absorbance data matrix mentioned above and
the concentration data matrix prepared as the concentrations in the mixtures for the prediction of the unknown
concentrations of DIF and CHL in their binary mixtures.
Good results were obtained by using standardized data in
calculation procedures. Two factorial four level design
was used for Design of Experiments (DOE) in the preparation of training sets (Table 3).
The linearity parameters, mean recoveries, relative standard deviations and confidence interval for this
method shown in Table 4. Linearity was found in the
range of 0.88-3.00 µg/mL for DIF and 1.0-11.2 µg/mL for
CHL. LOQ values were selected as 0.88 µg/mL for DIF
and 1.0 µg/mL for CHL. LOD values were calculated as
0.32 and 0.30 µg/mL for DIF and CHL respectively (Table
4). For calculations we used algoritms as described in
the literatures (9,10).
To select the number of factors, in order to model
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the system without overfitting the concentration data in
PCR algorithm, a cross-validation method, leaving out
one sample at a time was employed using training sets.
In this technique; three factors for DIF and CHL in their
binary mixture were found optimal for the determinations. We obtained the prediction error sum of squares
(PRESS) minimum with these factors (Table 5).
The predictive ability of a model can be defined in
various ways. The most general expression is the standard error of prediction (SEP). Another statistical value
is the SEC (standard error of calibration). SEP and SEC
were calculated and illustrated in Table 5.
These results for the application of PCR method to
the same binary mixture are shown in Table 5 and were
found satisfactory.
III. Precision
The precision was determined by means of one-way
ANOVA including 10 replicates carried out on three
successive days by PCR method and LC method for

Table 5. Summary of statistics in PCR method for DIF and CHL in
the mixture

synthetic mixtures of DIF and CHL. Snedecor F values
below the tabulated levels were obtained in all cases
(F = 4.21, n1 = 2, n 2 = 27; Table 6), so there were no
significant differences among the results obtained in the
determination of each drug in the presence of other on 3
different days (Table 6).
IV. Applications
Comparison of the spectra of DIF and CHL in standard and drug formulation solutions indicated that the
λ max in the zero-order spectra did not change and after
the addition of known amount of active ingredients to
the commercial formulations, the amount of these drugs
did not change. In LC method, no interfering peak was
observed in the chromatogram of the commercial cream
formulations in our conditions (Figure 4A). Also, as
seen in the chromatogram of the placebo in the same
conditions (Figure 4B), the excipients placed in the
commercial formulation did not interfere the quantitation
of DIF and CHL. All the results obtained by the meth-

Table 6. Analysis of variance (ANOVA) for the proposed methods
PCR

SEP
DIF

0.030

CHL

0.027
SEC

DIF

0.032

CHL

0.029
PRESS

DIF

0.005

CHL

0.006

mAU

a

500

c

LC

CHL

DIF

CHL

DIF

Between-days variance

0.062

0.074

0.067

0.096

Within-days variance

0.197

0.203

0.200

0.370

F ratio

3.18

2.74

3.03

3.85

Mean value

41.7

63.6

40.6

62.8

Between-days RSD (%)

0.072

0.134

0.080

0.152

Within-days RSD (%)

0.017

0.078

0.030

0.072

Between-day and within-day degrees of freedom 2 and 27 respectively. The critical F ratio value for 2 and 27 degrees of freedom and
a confidence level of 95% is 4.21.

(A)

4.460

2.520

(B)

mAU
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3.448
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Figure 4. Chromatogram of (A) cream preparation; a) ephedrine (internal standard), b) DIF and c) CHL, (B) placebo in LC method
developed.

150
Journal of Food and Drug Analysis, Vol. 15, No. 2, 2007

ods described above were compared statistically with
each other and no significant difference was observed for
the amount of drugs found theoretical values for t in p =
0.05 level for commercial formulations (Table 7).

Table 7. Assay results of commercial preparations (NERISONA C
cream) and (IMPETEX cream) (Label claims = 10 mg CHL and 1
mg DIF/1 g cream)
Methods

DIF

CHL

mean* ± SD**

CONCLUSIONS
In this study, a new LC method and PCR method
in spectrophotometry were developed for the simultaneous analysis of DIF + CHL combination. These methods
could be applied with great success for the simultaneous
determination of DIF and CHL in their binary mixtures
and in two pharmaceutical cream preparations. Generally, it is very difficult to study the cream preparations and
often it is necessary to do an extraction, which is a timeconsuming and precision-decreasing procedure in the
assay, prior to the application of analytical methods. Our
methods described in this work don’t need any prior separation procedure. Satisfactory results were obtained by
these methods, but, PCR method needs softwares for mathematical calculations. Using only zero-order spectra in
the procedures without any other graphical mode such as
derivative and ratio spectra derivative, is one of the advantages for the chemometric methods. Without any timeconsuming preparation procedures and methanol/water
mixture as solvent, spectrophotometric method proposed
in this article is easier and cheaper when compared with
the LC method. Both methods proposed in this article
were compared with each other due to the absence of official or published method for the simultaneous analysis of
DIF and CHL in their binary mixture. These methods were
found suitable for the simple and precise routine analysis
of the pharmaceutical preparations selected. Good agreement was achieved in the assay results of pharmaceutical
preparations widely used in Turkey, such as cream, for two
methods proposed in the text.
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